Acquisitions, biologics, enabling technology and loss of market share by the big players all made our list. Read the specifics and access our projections for 2019 revenue by company and segment.
Two of the 13 clearances address foot, ankle and toe. The remainder are spine products from large companies like Stryker and DePuy Synthes, to lesser-knowns like Kalitec Medical and Addivation.
Driven by an economic recovery and the impact of private equity, contract manufacturers are adding capabilities and service lines. An infographic shows how this has redefined the players over 10 years.
3D printing has the potential to do just that. With growth of the technology, though, comes the need for a harmonized approach to guidelines and standards.
“Our technology is delivering regenerative factors, specifically growth factors, locally to an injured site and has a time-release mechanism,” says CEO Randy Hubbell.
Meeting regulations and standards is not a simple task. To simplify quality management and improve accuracy, orthopedic manufacturers are choosing sophisticated force measurement and metrology systems to test their devices.
Dr. Steven Sampson, founder of the well-known TOBI Symposium, shares his take on the state of regenerative medicine and important areas of focus in the coming years.
Registration opens February 2020. Booth applications can be completed here.
Exhibitor In-Booth Presentations are back for 2020!
The call for abstracts will be sent in January. Want to be sure you receive an invitation? Contact
Brad Frey.
Begin identifying your next new partner by perusing this
confirmed list of exhibitors. The exhibit floor is 80% reserved!
The JOURNEY II Uni Knee is designed to bring the natural feel of JOURNEY II to partial knee arthroplasty patients and help drive value in healthcare systems.
At OMTEC, experts from Autocam Medical, MicroPort Orthopedics, Orchid and Zimmer Biomet spoke on EU MDR challenges, third-party audits and the need for more consistency in validations.
